GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$233.08−10.17 (-4.18%)
Close on Nov 18, 2026Market cap $13.80BP/E –Yield –
Glaukos operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Glaukos's operating income for the twelve months ending Sep 30, 2026 was -$176.16M. For fiscal 2025 it was -$199.60M. The highest annual figure on record is $4.24M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$199.60M | – |
| FY2024 | Dec 31, 2024 | -$122.37M | – |
| FY2023 | Dec 31, 2023 | -$128.70M | – |
| FY2022 | Dec 31, 2022 | -$82.31M | – |
| FY2021 | Dec 31, 2021 | -$32.87M | – |
| FY2020 | Dec 31, 2020 | -$123.55M | – |
| FY2019 | Dec 31, 2019 | -$50.29M | – |
| FY2018 | Dec 31, 2018 | -$13.00M | – |
| FY2017 | Dec 31, 2017 | -$2.28M | -153.8% |
| FY2016 | Dec 31, 2016 | $4.24M | – |
| FY2015 | Dec 31, 2015 | -$10.30M | – |
| FY2014 | Dec 31, 2014 | -$13.17M | – |
| FY2013 | Dec 31, 2013 | -$14.20M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $828.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$17.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.86M | – |
| Q4 FY2025 | Dec 31, 2025 | -$139.87M | – |
| Q3 FY2025 | Sep 30, 2025 | -$16.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$22.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$28.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$29.97M | – |
| Q1 FY2024 | Mar 31, 2024 | -$39.07M | – |
| Q4 FY2023 | Dec 31, 2023 | -$38.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$29.08M | – |
| Q1 FY2023 | Mar 31, 2023 | -$32.99M | -436.9% |
| Q4 FY2022 | Dec 31, 2022 | -$33.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.61M | -296.0% |
| Q2 FY2022 | Jun 30, 2022 | -$36.76M | – |
| Q1 FY2022 | Mar 31, 2022 | $9.79M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.87M | – |
| Q3 FY2021 | Sep 30, 2021 | $11.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.22M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$11.39M | – |
| Q3 FY2020 | Sep 30, 2020 | -$12.35M | – |
| Q2 FY2020 | Jun 30, 2020 | -$47.20M | – |
| Q1 FY2020 | Mar 31, 2020 | -$52.61M | – |
| Q4 FY2019 | Dec 31, 2019 | -$29.70M | -1665.5% |
| Q3 FY2019 | Sep 30, 2019 | -$12.42M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.24M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.94M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.90M | +256.6% |
| Q3 FY2018 | Sep 30, 2018 | -$6.94M | -1027.4% |
| Q2 FY2018 | Jun 30, 2018 | -$4.25M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.71M | -1321.7% |
| Q4 FY2017 | Dec 31, 2017 | $532.00K | +13.7% |
| Q3 FY2017 | Sep 30, 2017 | $748.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.87M | – |
| Q1 FY2017 | Mar 31, 2017 | $304.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $468.00K | – |
See a number that looks wrong?